![From QSR to QMSR: Meeting FDA’s New Requirements From QSR to QMSR: Meeting FDA’s New Requirements](https://www.fdanews.com/ext/resources/Book-Covers-NEW/From-QSR-to-QMSR-500.png?height=200&t=1714569011&width=200)
Home » Diatos and Servier Announce Oncology Research Collaboration
Diatos and Servier Announce Oncology Research Collaboration
May 18, 2005
Diatos S.A., a Paris-based privately held biopharmaceutical company, and Servier, France's largest privately owned pharmaceutical company, announced a research collaboration involving FTE support and a license option to apply the Diatos Vectocell technology to Servier's oncology research program in order to enhance the efficacy and safety of a Servier small molecule drug candidate.
KEYWORDS Daily International Pharma Alert
Upcoming Events
-
21Oct